Skip to content
Open access

The bacterial pH gradient contributes to persistence in Mycobacterium tuberculosis

Aug 2026 · mBio · Vol 17 · 0 citations · 72 references
Medicine

TL;DR

NC protected Mtb from lethal doses of most standard TB drugs, and showed that disruption of the pH gradient and consequent intracellular acidification is needed to induce tolerance, and that protection is tunable by external pH.

Abstract

ABSTRACT Tuberculosis (TB) remains difficult to cure due in part to poorly defined drug-tolerant persister cells formed by Mycobacterium tuberculosis (Mtb), which survive antibiotic treatment without evidence of genetic resistance. To better define this phenotype, we screened 2,336 U.S. Food and Drug Administration-approved drugs for compounds that target persistence. Unexpectedly, we identified a strong inducer of drug tolerance—the antiparasitic niclosamide (NCA), which is known to disrupt proton motive force. In contrast to earlier reports that it harbors promising anti-TB activity, we found that NCA protected Mtb from bactericidal doses of isoniazid, rifampicin, and other standard TB drugs. Investigating further, we showed that disruption of the pH gradient and consequent intracellular acidification is needed to induce tolerance, while disruption of membrane potential is not, and also that protection is tunable by external pH. Transcriptomic analysis of these chemically induced persister cells implicated Mtb-specific genes in this phenotype, and targeted knockdowns confirmed roles for three genes in either promoting or mitigating the tolerant state. These findings highlight that chemical disruption of the pH gradient is a facile and rapid means to induce drug tolerance, offering a potentially useful tool to probe persister biology in TB and other infectious diseases. IMPORTANCE Tuberculosis (TB) is difficult to cure due in part to poorly defined drug-tolerant persister cells formed by Mycobacterium tuberculosis (Mtb) that survive antibiotic treatment without genetic resistance. In this work, we screened for drugs that target persistence. Unexpectedly, we identified a strong inducer of drug tolerance—the antiparasitic agent niclosamide (NCA), which is known to disrupt proton motive force. We found that NCA protected Mtb from lethal doses of most standard TB drugs. We showed that disruption of the pH gradient and consequent intracellular acidification is needed to induce tolerance, and that protection is tunable by external pH. We identified three Mtb genes that contribute to either promoting or mitigating the tolerant state. These findings highlight that chemical disruption of the pH gradient is a facile and rapid way to induce drug tolerance, offering a potentially useful tool to probe persister biology in TB and other infectious diseases. Tuberculosis (TB) is difficult to cure due in part to poorly defined drug-tolerant persister cells formed by Mycobacterium tuberculosis (Mtb) that survive antibiotic treatment without genetic resistance. In this work, we screened for drugs that target persistence. Unexpectedly, we identified a strong inducer of drug tolerance—the antiparasitic agent niclosamide (NCA), which is known to disrupt proton motive force. We found that NCA protected Mtb from lethal doses of most standard TB drugs. We showed that disruption of the pH gradient and consequent intracellular acidification is needed to induce tolerance, and that protection is tunable by external pH. We identified three Mtb genes that contribute to either promoting or mitigating the tolerant state. These findings highlight that chemical disruption of the pH gradient is a facile and rapid way to induce drug tolerance, offering a potentially useful tool to probe persister biology in TB and other infectious diseases.

Read PDF

Similar papers

Open access Sep 2026

The Phosphate-Specific Transport System Gene pstA1 Contributes to Rifampin Tolerance in Mycobacterium tuberculosis.

BACKGROUND Tuberculosis (TB) caused an estimated 10.7 million new cases and 1.23 million deaths in 2024. Antibiotic tolerance, the ability of bacteria to survive bactericidal antibiotics without genetic resistance mutations, contributes to prolonged treatment. Targeting tolerance mechanisms could promote accelerated cl...

Carina Danchik, G. V. Anoushka Chinmayi, Gi-Yong Lee et al. · 0 citations
Open access Sep 2026

Rv3787c Influences Growth Dynamics of Mycobacterium tuberculosis

Simple Summary Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, remains one of the world’s deadliest infectious diseases. Identifying which bacterial genes aid survival and transmission could reveal new therapeutic targets. In this study, we studied Rv3787c, which belongs to a family of genes encoding...

M. M. Bigi, R. Rocha, E. García et al. · 0 citations
Open access Aug 2026

Desiccation promotes DNA damage and rifampin resistance in Mycobacterium tuberculosis.

Mycobacterium tuberculosis (Mtb) is an obligate human pathogen that depends on its ability to spread from host to host to survive as a species. Knowledge of traits supporting transmission is lacking. Here, because desiccation occurs during the generation of Mtb-transmitting aerosol droplets, we exposed Mtb mounted atop...

C. Brown, Brendon M. Lee, H. M. Liu et al. · 1 citation
Open access Oct 2026

Diethyl fumarate exhibits potent activity against differentially culturable Mycobacterium tuberculosis persisters

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains the leading cause of death from a single infectious agent. During infection, Mtb forms drug-tolerant persisters, including differentially culturable (DC) cells that fail to grow on solid media and contribute to prolonged TB treatment and disease...

Amelie J. Herbert, O. Turapov, Fraser Macdonald et al. · 0 citations
Open access Sep 2026

Development of GuaB Inhibitors to Treat Mycobacterium tuberculosis Infection

Mycobacterium tuberculosis (Mtb) is responsible for more deaths per year than any other infectious disease. Resistance of circulating Mtb to the standard of care treatment regimen is an urgent global health crisis for which novel antibiotic treatments are needed. We have developed extremely potent, orally bioavailabl...

Eric M. Kofoed, Terry D. Crawford, Christine M. Bowman et al. · 0 citations
Open access Aug 2026

Visualizing zinc-starved slow-replicating Mycobacterium tuberculosis in neutrophil-rich lung lesions

The months-long treatment for tuberculosis is partially attributed to a minor Mycobacterium tuberculosis (Mtb) subpopulation exhibiting phenotypic drug resistance, although origins of these bacilli in hosts remain unknown. Previously, we observed that mycobacteria respond to growth-restrictive limitations of zinc by ac...

Jamie H. Corro, Jordan Holl, V. Patil et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.